Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Dikranian · SciRah

Researcher profile · Semantic Scholar

A. Dikranian

Share profile

A. Dikranian — researcher profile on SciRah

h-index: 9
Works: 24
Citations: 1,262

Most-cited papers

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.
C. Gabay, P. Emery, R. van Vollenhoven, A. Dikranian +7 more
2013The Lancet677 citations Open access
Semantic Scholar
Treatment of rheumatoid arthritis with a Syk kinase inhibitor: a twelve-week, randomized, placebo-controlled trial.
M. Weinblatt, A. Kavanaugh, R. Burgos-Vargas, A. Dikranian +7 more
2008Arthritis & Rheumatism355 citations
Semantic Scholar
A Randomized, Double‐Blind, Sham‐Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis
Matthew C. Baker, Sarah Kavanagh, S. Cohen, A. Matsumoto +5 more
2023Arthritis & Rheumatology44 citations
Semantic Scholar
Comparison of patient and physician perspectives in the management of rheumatoid arthritis: results from global physician- and patient-based surveys
A. Gibofsky, J. Galloway, J. Kekow, C. Zerbini +10 more
2018Health and Quality of Life Outcomes38 citations Open access
Semantic Scholar
Model‐Informed Development and Registration of a Once‐Daily Regimen of Extended‐Release Tofacitinib
M. Lamba, M. Hutmacher, D. E. Furst, A. Dikranian +6 more
2017Clinical pharmacology and therapy34 citations Open access
Semantic Scholar
LB0003 Tocilizumab (TCZ) monotherapy is superior to adalimumab (ADA) monotherapy in reducing disease activity in patients with rheumatoid arthritis (RA): 24-week data from the phase 4 adacta trial
C. Gabay, P. Emery, R. van Vollenhoven, A. Dikranian +6 more
201227 citations
Semantic Scholar
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index: an analysis of pooled data from phase 3 studies
A. Dikranian, M. González-Gay, F. Wellborne, J. Álvaro-Gracia +6 more
2022RMD Open26 citations Open access
Semantic Scholar
Treatment patterns, unmet need, and impact on patient-reported outcomes of psoriatic arthritis in the United States and Europe
A. Gottlieb, J. Gratacós, A. Dikranian, A. van Tubergen +5 more
2018Rheumatology International26 citations Open access
Semantic Scholar
Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials
V. Strand, E. B. Lee, Y. Yazici, A. Dikranian +5 more
2018Clinical Rheumatology10 citations Open access
Semantic Scholar
H.P. Acthar® Gel in Dermatomyositis and Polymyositis Treatment Registry: An Interim Analysis
T. Levine, J. Malone, P. Efthimiou, R. Tandan +3 more
20168 citations
Semantic Scholar
Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib
A. Dikranian, D. Gold, L. Bessette, P. Nash +7 more
2021Rheumatology and Therapy4 citations Open access
Semantic Scholar
AB0247 INSIGHTS INTO ADHERENCE AND PATIENT-INITIATED MONOTHERAPY FOR RHEUMATOID ARTHRITIS VIA A GLOBAL SURVEY OF PATIENTS, CAREGIVERS AND PHYSICIANS
J. Galloway, A. Dikranian, C. Koehn, D. Gruben +2 more
2019Abstracts Accepted for Publication3 citations Open access
Semantic Scholar
OP0248-PARE Understanding The Importance of A Patient's Role in The Management of Ra: Results from A Patient-Based Survey Developed by The Ra Narrative Global Advisory Panel
C. Koehn, A. Dikranian, A. Maniccia, E. Bananis
20163 citations
Semantic Scholar
SAT0127 The efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index
A. Dikranian, M. González-Gay, F. Wellborne, J. Álvaro-Gracia +6 more
2018Saturday, 16 JUNE 20182 citations Open access
Semantic Scholar
analysis of Early Neutropenia, Clinical Response, and Serious Infection Events in Patients Receiving Tofacitinib for Rheumatoid Arthritis. : 2489
V. Strand, A. Dikranian, J. Beal, K. Kwok +3 more
20142 citations
Semantic Scholar
Characteristics and 6-Month Outcomes in Patients with Rheumatoid Arthritis Initiating Infliximab Biosimilar IFX-dyyb in a Real-World Setting
Joshua F. Baker, C. Bakewell, A. Dikranian, Gordon K. Lam +5 more
2024Rheumatology and Therapy1 citations Open access
Semantic Scholar
AB0705 LONG TERM SAFETY OF CONVENTIONAL AND BIOLOGIC IL-6RI IMMUNOMODULATORS AS SECOND-LINE (2L) OR THIRD-LINE (3L) TREATMENT OF POLYMYALGIA RHEUMATICA
A. Dikranian, C. Calabrese, C. Bingham, S. Fiore +4 more
2023Annals of the Rheumatic Diseases1 citations Open access
Semantic Scholar
Frequency and Duration of Early Non-Serious Adverse Events in Rheumatoid Arthritis Patients Treated with Tofacitinib 5 Mg Twice Daily As Monotherapy and Combination Therapy
A. Dikranian, J. Wollenhaupt, V. Azevedo, L. Bessette +7 more
20181 citations
Semantic Scholar
Switching From Immediate-Release to Delayed-Release Prednisone in Moderate to Severe Rheumatoid Arthritis: A Practice-Based Clinical Study
A. Dikranian, R. Mallay, M. Marshall, M. Francis-Sedlak +1 more
2017Rheumatology and Therapy1 citations Open access
Semantic Scholar
Effectiveness and safety of interleukin 6 receptor inhibitors versus conventional immunomodulatory therapy in steroid-refractory polymyalgia rheumatica
A. Dua, R. Spiera, A. Dikranian, C. Calabrese +8 more
2026RMD Open0 citations Open access
Semantic Scholar
AB0454 FREQUENCY AND DURATION OF EARLY NON-SERIOUS ADVERSE EVENTS IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH TOFACITINIB 5 MG TWICE DAILY AS MONOTHERAPY AND COMBINATION THERAPY
A. Dikranian, J. Wollenhaupt, V. Azevedo, L. Bessette +7 more
2019Abstracts Accepted for Publication0 citations Open access
Semantic Scholar
FRI0484 Impact of psoriatic arthritis on patient-reported outcomes in 5 european union countries
A. Gottlieb, J. Gratacós, A. Dikranian, L. Fallon +4 more
20170 citations Open access
Semantic Scholar
SAT0640-HPR Understanding The Importance of A Patient's Role in The Management of RA: Physician- and Patient-Based Survey Results Developed by The RA Narrative Advisory Panel
A. Dikranian, J. Galloway, J. Kekow, C. Zerbini +6 more
20160 citations
Semantic Scholar
THU0192 Evaluating Pharmacokinetic Predictors of Tofacitinib Clinical Response in Rheumatoid Arthritis
M. Lamba, D. E. Furst, A. Dikranian, Martin E. Dowty +5 more
20160 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Bananis×4
Invite
E. Bananis — researcher profile on SciRah
J. Woolcott×4
Invite
J. Woolcott — researcher profile on SciRah
C. Koehn×3
Invite
C. Koehn — researcher profile on SciRah
A. Maniccia×3
Invite
A. Maniccia — researcher profile on SciRah

S. Krishnaswami

×3

Invite

S. Krishnaswami — researcher profile on SciRah

Invite

Harry Shi — researcher profile on SciRah

Invite

D. Gold — researcher profile on SciRah

Invite

L. Bessette — researcher profile on SciRah

Invite

P. Nash — researcher profile on SciRah

Invite

V. Azevedo — researcher profile on SciRah

Invite

Lisy Wang — researcher profile on SciRah

Andrea Shapiro×3

Invite

Andrea Shapiro — researcher profile on SciRah